Irritable Bowel Syndrome Canine

Most people have this notion that irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) are one and the same. This can prove problematic when it comes to canine care because the two terms are very much dissimilar. Many dog owners have fallen prey to this misconception and, as a consequence, have given their pets the wrong treatment. It is important that the right information be obtained before any diagnosis concerning irritable bowel...

 

Irritable Bowel Syndrome Diet

Irritable bowel syndrome, simply called as IBS, is a functional bowel disorder in which the intestines of the person affected either squeeze too hard or just not hard enough, causing food to either move too quickly or too slowly in the intestines. IBS is more common in women and normally starts at the young age of 20. While IBS has no permanent cure, there are treatments that can relieve the disorder’s symptoms. One of the most effective of these...

 

Irritable Bowel Syndrome Drugs

Irritable bowel syndrome, also known as IBS, is a functional bowel syndrome that is commonly characterized by cramps, abdominal pain, gas, bloating, diarrhea, constipation, and irregularities in bowel habits. While this particular bowel disorder has no known cure, its symptoms can be treated with a number of things, including alterations in diet, stress relief, and medication. Medications for irritable bowel syndrome usually consist of laxatives and...

 

Irritable Bowel Syndrome Probiotics

Irritable bowel syndrome, simply called as IBS, is a functional bowel disorder in which the intestines of the person affected either squeeze too hard or just not hard enough, causing food to either move too quickly or too slowly in the intestines. IBS is more common in women and normally starts at the young age of 20. While IBS has no permanent cure, there are treatments that can relieve the disorder’s symptoms. One of the most effective of these...

 

Irritable Bowel Syndrome Symptoms

Irritable bowel syndrome, simply referred to as IBS, is known in gastroenterology as a functional bowel disorder that may begin after the person affected has had an infection or underwent a traumatic or stressful life event. IBS is said to exist more often with other functional disorders and psychological conditions. Women are more likely to suffer from IBS, which can start to manifest itself when the person is only 20 years old. But no matter what...

 

Irritable Bowel Syndrome Treatments

Irritable bowel syndrome or IBS is a functional bowel syndrome that attacks the intestines and causes problems in bowel movement. People who suffer from IBS usually experience a wide variety of symptoms, including abdominal pain or discomfort, diarrhea, constipation, mucus-filled stool, unexplainable feeling of wanting to go again right after bowel movement, and other changes in bowel habits. One fact that people need to know about irritable bowel...

 

Irritable Bowel Syndrome Alternative Treatments

Irritable bowel syndrome or IBS is a functional bowel syndrome that attacks the intestines and causes problems in bowel movement. People who suffer from IBS usually experience a variety of symptoms, including abdominal pain or discomfort, diarrhea, constipation, mucus-filled stool, unexplainable feeling of wanting to go again right after bowel movement, and other changes in bowel habits. One fact that people need to know about irritable bowel syndrome...

 

Largest Gene Study In Childhood IBD Finds 5 New Genes

In the largest, most comprehensive genetic analysis of childhood-onset inflammatory bowel disease (IBD), an international research team has identified five new gene regions, including one involved in a biological pathway that helps drive the painful inflammation of the digestive tract that characterizes the disease. A research team led by Hakon Hakonarson, M.D., Ph.D. Share on Facebook

 

Ironwood And Forest Announce Positive Linaclotide Results From Two Pivotal Phase 3 Trials In Patients With Chronic Constipation

Ironwood Pharmaceuticals, Inc. and Forest Laboratories, Inc. (NYSE: FRX) today announced positive top-line results from two Phase 3 clinical trials assessing the safety and efficacy of once-daily dosing of the investigational drug linaclotide in patients with chronic constipation (CC). Share on Facebook

 

Lexicon Announces Positive Phase 2 Results Of LX1031 In Non-Constipating Irritable Bowel Syndrome

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced that the company’s investigational new drug, LX1031, a tryptophan hydroxylase (TPH) inhibitor, demonstrated positive results in clinically important parameters for the treatment of non-constipating irritable bowel syndrome (IBS). Share on Facebook